{
    "2020-11-10": [
        [
            {
                "time": "",
                "original_text": "疫苗数据引爆全球市场，A股市场怎么走？",
                "features": {
                    "keywords": [
                        "疫苗",
                        "数据",
                        "全球市场",
                        "A股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中信证券：BNT162b2新冠疫苗结果超预期，有望为相关企业业绩带来较大弹性",
                "features": {
                    "keywords": [
                        "中信证券",
                        "BNT162b2",
                        "新冠疫苗",
                        "超预期",
                        "业绩弹性"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中信证券：BNT162b2新冠疫苗结果超预期 有望为相关企业业绩带来较大弹性",
                "features": {
                    "keywords": [
                        "中信证券",
                        "BNT162b2",
                        "新冠疫苗",
                        "超预期",
                        "业绩弹性"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：与合作方共同合作研发的新型冠状病毒mRNA疫苗目前处于一期临床试验阶段",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "mRNA疫苗",
                        "一期临床试验"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}